Business Description
Steris PLC
NAICS : 339113
SIC : 5047
5960 Heisley Road, Mentor, OH, USA, 44060
Description
Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.44 | |||||
| Debt-to-EBITDA | 2.74 | |||||
| Interest Coverage | 8.41 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.36 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.7 | |||||
| 3-Year EBITDA Growth Rate | 9.1 | |||||
| 3-Year EPS without NRI Growth Rate | -11.3 | |||||
| 3-Year FCF Growth Rate | -0.4 | |||||
| 3-Year Book Growth Rate | 20.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 5.05 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 16.49 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.47 | |||||
| 9-Day RSI | 45.97 | |||||
| 14-Day RSI | 47.73 | |||||
| 6-1 Month Momentum % | -7.62 | |||||
| 12-1 Month Momentum % | -3.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.03 | |||||
| Quick Ratio | 1.35 | |||||
| Cash Ratio | 0.35 | |||||
| Days Inventory | 80.73 | |||||
| Days Sales Outstanding | 58.43 | |||||
| Days Payable | 30.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.81 | |||||
| Dividend Payout Ratio | 0.45 | |||||
| 3-Year Dividend Growth Rate | 8.3 | |||||
| Forward Dividend Yield % | 0.89 | |||||
| 5-Year Yield-on-Cost % | 1.25 | |||||
| 3-Year Average Share Buyback Ratio | -5.8 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.16 | |||||
| Operating Margin % | 11.94 | |||||
| Net Margin % | 7.9 | |||||
| ROE % | 5.77 | |||||
| ROA % | 3.24 | |||||
| ROIC % | 4.11 | |||||
| ROC (Joel Greenblatt) % | 22.97 | |||||
| ROCE % | 5.33 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 56.83 | |||||
| Forward PE Ratio | 22.68 | |||||
| PE Ratio without NRI | 56.83 | |||||
| Shiller PE Ratio | 62.41 | |||||
| Price-to-Owner-Earnings | 56.26 | |||||
| PEG Ratio | 4.18 | |||||
| PS Ratio | 4.47 | |||||
| PB Ratio | 3.3 | |||||
| Price-to-Free-Cash-Flow | 45.25 | |||||
| Price-to-Operating-Cash-Flow | 26.07 | |||||
| EV-to-EBIT | 41.68 | |||||
| EV-to-Forward-EBIT | 30.26 | |||||
| EV-to-EBITDA | 22.85 | |||||
| EV-to-Forward-EBITDA | 21.53 | |||||
| EV-to-Revenue | 4.97 | |||||
| EV-to-Forward-Revenue | 4.69 | |||||
| EV-to-FCF | 50.3 | |||||
| Price-to-Projected-FCF | 2.19 | |||||
| Price-to-Median-PS-Value | 1.62 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.05 | |||||
| Earnings Yield (Greenblatt) % | 2.4 | |||||
| Forward Rate of Return (Yacktman) % | 13.25 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NYSE:STE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4,773.133 | ||
| EPS (TTM) ($) | 3.73 | ||
| Beta | 0.69 | ||
| Volatility % | 28.53 | ||
| 14-Day RSI | 47.73 | ||
| 14-Day ATR ($) | 6.216158 | ||
| 20-Day SMA ($) | 214.4905 | ||
| 12-1 Month Momentum % | -3.16 | ||
| 52-Week Range ($) | 192.4003 - 255.9325 | ||
| Shares Outstanding (Mil) | 100.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Steris PLC Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||